Materials & Chemicals Market Research News

Research focused on the Global anticoagulants market trends & forecasts 2017-2021 focused on US market

Materials & Chemicals Research

The report also assesses the key opportunities available in the market and outline the market dynamics that are and will be accountable for growth of the industry. Growth of the global anticoagulants market has also been forecasted for the period 2017-2021, taking into consideration previous growth outlines, growth drivers and the existing and forthcoming trends.Bayer, BMS/Pfizer, Boehringher Ingelheim and Daiichi Sanky are some of key players featured in this report.

Research By Markets adds "Global Anticoagulants Market: Size…casts (2017-2021) Make an Inquiry about this news" to its online repository. The report provides an in-depth analysis of the global anticoagulants market with description of market size and growth.

The analysis include market share by treatment, by segment, and by products.

The report also provides analysis of injectable and oral anticoagulants available in the market.

Details of Lovenox, Arixtra, Xarelto, Eliquis, Pradaxa and Savaysa has been provided in the report in terms of their global sales.

A brief analysis of the US Anticoagulants Market has also been provided in terms of value and sales of top four oral anticoagulant drugs in the region.

Bayer, BMS/Pfizer, Boehringher Ingelheim and Daiichi Sankyo are some of the key players operating in the global anticoagulants market, whose company profiling has been done in the report. This segment summarizes business overview, financial overview and the business strategies of the companies.

For more information about this report: www.researchbymarkets.com/report/g…17-2021-4973.html Make an Inquiry about this news

Executive Summary

Anticoagulants which are also known as blood thinners are drugs that are prescribed to prevent blood from clotting or stop existing clots from getting larger. The drugs prevent harmful clots forming in heart, veins or arteries.

Formation of clots in the blood can lead to heart attack or stroke. These drugs are used to treat strokes, myocardial infarctions, pulmonary embolisms, disseminated intravascular coagulation (DIC) and deep vein thrombosis (DVT)- all potentially life-threatening conditions.

Anticoagulants work by interrupting the process involved in the formation of blood clots.

The most commonly prescribed anticoagulant is Warfarin. Newer types of anticoagulants are also available and are becoming increasingly common.

These include rivaroxaban (Xarelto), dabigatran (Pradaxa), apixaban (Eliquis), and edoxaban (Savaysa/Lixiana). Warfarin and the newer alternatives are taken as tablets or capsules.

There's also an anticoagulant called heparin that can be given by injection.

Company Coverage

Bayer Group
BMS/Pfizer
Boehringher Ingelheim
Daiichi Sankyo

Country Coverage

United States of America

Key Topics Covered:

1. Executive Summary
2. Introduction
3. Global Market Analysis
4. Global Anticoagulants Product Analysis
5. Region/Country Analysis
6. Market Dynamics
7. Competitive Landscape
8. Company Profiling

News From

Research By MarketsResearch By Markets
Category: Market Research Publishers and RetailersCompany about: Research by Markets is an online Market Research Report Repository. Our repository contains reports segmented by Geography and Industry. We cover all major Industry Verticals - Information Technology, Semiconductor, Electronics, Manufacturing, Food & Beverages, Telecommunications, Healthcare, Pharmaceutical, Automotive, BioTechnology, Energy & Power, Banking and many more. We have dedicated Account Managers for Corporate Clients to ensure seamless customer support. Corporates can als ...
This email address is being protected from spambots. You need JavaScript enabled to view it.

For more information:

Make an Inquiry about this report HERE!
  • www.researchbymarkets.com/report/g…17-2021-4973.html
  • www.researchbymarkets.com/paynow/4973
  • www.researchbymarkets.com